Jessie J admitted to hospital weeks after cancer surgery
Jessie said she has since discharged herself from the same hospital where she was treated after breast cancer surgery, announcing in July that she had since seen 'no cancer spread'.
A post shared by Jessie J (@jessiej)
In a post on Instagram, the Price Tag singer told her followers: 'Six weeks post surgery and I was back in the same ward I was after my surgery. Not expected or planned.
'I had and still have symptoms that pointed towards a blood clot on the lung, it is not a blood clot thank god.
'They ran a lot of tests, which ended up showing I have an infection (still trying to figure out what) and a little fluid on my lungs.
'Finding it hard to breathe in, but I discharged myself last night (I hate being in hospital) and will continue the investigation as an outpatient.'
She went on to say it was 'frustrating' that her career plans had to change due to her surgery and hospital visits, and added that she had been 'working so hard to get to this point and excited to do it all'.
Jessie continued: 'I know for me, the true hard journey of this whole thing physically was the day I went into surgery.
'The recovery physically is far from quick or easy, and mentally it's been the most challenging time for me, especially as a mum with a toddler and being unable to be the mother I usually am.'
The former coach on The Voice said her visit to hospital was a 'reminder to myself to slow down' even though she felt she was already at a slow pace.
Recommended reading:
Singer Jessie J diagnosed with 'early breast cancer' and reveals surgery plans
Freddie Flintoff praises NHS staff who cared for him after serious car crash
Michael Palin 'slightly unsteady' as he admits he's 'prepared for death'
Jessie added: 'This isn't a speedy recovery and it isn't meant to be.
'As an ADHD Aries, fire breathing dragon t-rex, I can do it myself, I'm always ok woman. That slow pace has been a hard reality to accept to be honest.
'I love moving and working and being up and active but I can't be right now, and that's what it is, and I am finding the strength knowing that all can be adjusted to align with a slower pace and the support of my very small inner support circle.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
24 minutes ago
- The Independent
NHS issues vaccination warning for pregnant women over dangerous virus currently surging in Australia
Expectant mothers and people over 75 are being urged to get vaccinated against a potentially deadly virus following a record number of cases in Australia. Health chiefs say the Australian winter often predicts how viruses will spread in the UK, and already this year cases of respiratory syncytial virus (RSV) have steadily risen in many areas. The virus, which is a common cause of coughs and colds, may also cause a chest infection called bronchiolitis. Some people have a high risk of becoming seriously ill with it, including babies and adults over 75. According to NHS England, RSV is a leading cause of infant deaths worldwide and a main cause of children being taken into hospital. Last winter, almost 7,000 bed days in England were taken up by children with RSV. NHS England is encouraging pregnant women to get a jab that protects against RSV so their babies are protected after birth. Kate Brintworth, chief midwifery officer for NHS England, said: 'While for most adults RSV only causes mild, cold-like symptoms, for older adults and young children it can lead to serious breathing problems that can end up in hospitalisation. 'Getting vaccinated while pregnant is the best way to protect your baby from the moment they are born, and now is the time for mums to act, to make sure their babies are protected ahead of their first few months this winter, when there tends to be more bugs circulating.' Yusra Osman says that when her son, Zakariya, was three months old, he developed bronchiolitis from the virus. He had a fever and was gasping for breath. The 34-year-old, from north London, said: 'Everything was a blur, but I remember his chest was caving in and out and he was really struggling to catch his breath.' Nurses found her son's oxygen levels were dangerously low. Ms Osman, a student midwife, said: 'That was one of those things you don't want to hear as a mum. He was crying, and we kept trying to put an oxygen mask on, but he was fighting to get it off and didn't want to be touched.' Zakariya, who is now seven, needed oxygen and a feeding tube in hospital. 'It's a mum's worst nightmare. Had the RSV vaccine been available then, I'd definitely have had it,' Ms Osman said. The RSV vaccine was offered to pregnant women in England for the first time last September and health officials say it has since helped to protect more than 300,000 mothers and babies. Pregnant mothers from 28 weeks onwards are eligible, as are adults aged 75 to 79. In the coming weeks, NHS England is set to invite more than a million people to have a jab, before the season for infections, which starts in October. Greta Hayward, consultant midwife at the UK Health Security Agency, said babies born in late summer or the autumn are most likely to be admitted to hospital with the virus. 'Hundreds of babies attend emergency departments each day for bronchiolitis through most of November and December,' she said.
The Guardian
an hour ago
- The Guardian
OpenAI changes ChatGPT to stop it telling people to break up with partners
ChatGPT will not tell people to break up with their partner and will encourage users to take breaks from long chatbot sessions, under new changes to the artificial intelligence tool. OpenAI, ChatGPT's developer, said the chatbot would stop giving definitive answers to personal challenges and would instead help people mull over issues such as breakups. 'When you ask something like: 'Should I break up with my boyfriend?' ChatGPT shouldn't give you an answer. It should help you think it through – asking questions, weighing pros and cons,' said OpenAI. The US company said new ChatGPT behaviour for dealing with 'high-stakes personal decisions' would be rolling out soon. OpenAI admitted this year that an update to ChatGPT had made the groundbreaking chatbot too agreeable and altered its tone. In one reported interaction before the change, ChatGPT congratulated a user for 'standing up for yourself' when they claimed they had stopped taking their medication and left their family – who were supposedly 'responsible' for radio signals emanating from the walls. In the blog post OpenAI admitted there had been instances where its advanced 4o model had not recognised signs of delusion or emotional dependency – amid concerns that chatbots are worsening people's mental health crises. The company said it was developing tools to detect signs of mental or emotional distress so ChatGPT can direct people to 'evidence-based' resources for help. A recent study by NHS doctors in the UK warned that AI programs could amplify delusional or grandiose content in users vulnerable to psychosis. The study, which has not been peer reviewed, said this could be due in part to the models being designed to 'maximise engagement and affirmation'. The study added that even if some individuals benefitted from AI interactions, there was a concern the tools could 'blur reality boundaries and disrupt self-regulation'. OpenAI added that from this week it would send 'gentle reminders' to take a screen break to users engaging in long chatbot sessions, similar to screen-time features deployed by social media companies. OpenAI said it had convened an advisory group of experts in mental health, youth development and human-computer-interaction to guide its approach. The company has worked with more than 90 doctors including psychiatrists and paediatricians to build frameworks for evaluating 'complex, multi-turn' chatbot conversations. 'We hold ourselves to one test: if someone we love turned to ChatGPT for support, would we feel reassured? Getting to an unequivocal 'yes' is our work,' said the blog post. The ChatGPT alterations were announced amid speculation that a more powerful version of the chatbot is imminent. On Sunday Sam Altman, OpenAI's chief executive, shared a screenshot of what appeared to be the company's latest AI model, GPT-5.
The Independent
an hour ago
- The Independent
Thousands of patients miss out on weight loss jab due to NHS ‘postcode lottery'
Thousands of obese patients are missing out on a key weight loss jab due to a 'postcode lottery' of provision in the NHS, according to a report. Mounjaro, dubbed the 'King Kong' of weight loss medicine, was supposed to be available through GP surgeries from 23 June under an agreement between NHS England and NICE. But just eight out of 42 NHS Integrated Care Boards (ICBs) in England were able to provide treatment to patients, according to Sky News, who obtained the data using a Freedom of Information request. Many other ICBs were reportedly unable to confirm when treatment would be available. Dr Jonathan Hazlehurst, an endocrinologist and obesity physician at University Hospitals Birmingham, said patients were 'set up for failure' and have been treated unfairly. "Giving people open promises and setting them up for disappointment and failure is clearly grossly unfair. That's what the current system is doing,' he told the broadcaster. NICE said in December that the NHS should offer Mounjaro to patients with a BMI of over 40 and at least four clinical conditions related to their weight, such as heart disease or type 2 diabetes. It calculated from NHS England data that there were 97,500 patients who should be treated in the first year. But Dr Hazlehurst claims NHS England has only provided funding for just over 22,000 patients. The Independent has approached NHS England for comment. A spokesperson told Sky News that NHS England had "fully supported the rollout" of Mounjaro. "We issued guidance and provided funding in March to all Integrated Care Boards to support treatment costs, enable scaling of services and provide wrap-around care, including digital support services,' they said. It comes after NICE warned many individuals might regain weight if not adequately supported after ceasing treatment. It stressed that those coming off the drugs should be offered "structured advice and follow-up support" to mitigate weight gain. This guidance applies to individuals receiving these treatments through the NHS. However, an estimated 1.5 million people in the UK are currently using weight-loss injections, with the vast majority paying privately. These individuals will not be eligible for NHS support once their treatment concludes. The new 'quality standard' from NICE says that NHS patients should be monitored for at least a year after they complete treatment, and extra support should be offered if needed. It emphasises building 'long-term behavioural habits, use self-monitoring tools, and draw on wider support – from online communities to family-led interventions and local activities'. This standard, a type of guidance for the health services in England and Wales, sets out expectations for health providers including how they should support patients. 'Successful weight management doesn't end when medication stops or when someone completes a behavioural programme,' said Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice. 'We know that the transition period after treatment is crucial, and people need structured support to maintain the positive changes they've made.'
